Status
Study
Lead sponsor
Phase
Enrol
US states
Start
Recruiting
Solve Therapeutics
Phase 1
250
California, Missouri, New Jersey, New York, Ohio, Texas, Washington
2025-05-14
Active, closed
Alterome Therapeutics, Inc.
Phase 1
110
California, Colorado, Florida, Massachusetts, Missouri, Tennessee, Texas, Virginia
2024-08-22
Recruiting
MacroGenics
Phase 1
250
California, Michigan, New York, Oregon, Texas, Utah
2024-03-06
Active, closed
Mirati Therapeutics Inc.
Phase 2
200
California, Missouri, North Carolina, Texas
2024-02-01
Recruiting
OncoResponse, Inc.
Phase 1/2
168
Texas, Virginia
2023-10-24
Active, closed
Nectin Therapeutics Ltd
Phase 1
90
California, Louisiana, Texas
2022-09-01
Recruiting
Qurient Co., Ltd.
Phase 1/2
130
Arizona, California, Florida, Illinois, Minnesota, New Jersey, Texas
2022-08-30
Recruiting
Aulos Bioscience, Inc.
Phase 1/2
159
Florida, Michigan, Minnesota, Missouri, New Jersey, North Carolina, Tennessee, Texas
2022-04-04
Active, closed
invoX Pharma Limited
Phase 1
82
Connecticut, Texas, Utah
2020-11-18